Dr Ryan Haumschild Discusses Payer, Provider Perspectives on Prior Authorization in Rare Diseases
September 19th 2023Ryan Haumschild, PharmD, MS, MBA, director of pharmacy at Emory Winship Cancer Institute, shares his unique perspectives as both a provider and payer on the use of prior authorizations (PAs) and "Gold Cards" in patients with rare diseases.
Dr Tariq Cheema Discusses Patient, Family Experiences With Virtual ICU Care
September 18th 2023Tariq Cheema, MD, division chair of pulmonary critical care sleep and allergy medicine at Allegheny Health Network (AHN), discusses how the virtual ICU (vICU) program has benefited patients and their families during the COVID-19 pandemic in terms of both patient care and managing resources.
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Catherine Nester Discusses the BeginNGS Tool for Newborn Rare Disease Screening Awareness
August 25th 2023Catherine Nester, RN, vice president of physician and patient strategies at Inozyme Pharma, highlights the importance of newborn screening for rare diseases and the impact of the BeginNGS diagnostic tool.
Dr Gustavo Fonseca on Key Takeaways From an FCS Analysis on Clinical Trial Enrollment
August 19th 2023Gustavo Fonseca, MD, FACP, physician director of clinical research, Florida Cancer Specialists & Research Institute (FCS), discusses the results from a late phase complexity analysis on barriers to clinical trials regarding biopsy requirements.